Online citations, reference lists, and bibliographies.
← Back to Search

Tumor Targeting With Antibody-Functionalized, Radiolabeled Carbon Nanotubes

M. McDevitt, D. Chattopadhyay, B. Kappel, J. S. Jaggi, Scott R. Schiffman, C. Antczak, J. T. Njardarson, R. Brentjens, D. Scheinberg
Published 2007 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Single-walled carbon nanotubes (CNT) are mechanically robust graphene cylinders with a high aspect ratio that are comprised of sp2-bonded carbon atoms and possessing highly regular structures with defined periodicity. CNT exhibit unique mechanochemical properties that can be exploited for the development of novel drug delivery platforms. We hypothesized that novel prototype nanostructures consisting of biologics, radionuclides, fluorochromes, and CNT could be synthesized and designed to target tumor cells. Methods: Tumor-targeting CNT constructs were synthesized from sidewall-functionalized, water-soluble CNT platforms by covalently attaching multiple copies of tumor-specific monoclonal antibodies, radiometal-ion chelates, and fluorescent probes. The constructs were characterized spectroscopically, chromatographically, and electrophoretically. The specific reactivity of these constructs was evaluated in vitro by flow cytometry and cell-based immunoreactivity assays and in vivo using biodistribution in a murine xenograft model of lymphoma. Results: A soluble, reactive CNT platform was used as the starting point to build multifunctional constructs with appended antibody, metal-ion chelate, and fluorescent chromophore moieties to effect specific targeting, to carry and deliver a radiometal-ion, and to report location, respectively. These nanoconstructs were found to be specifically reactive with the human cancer cells they were designed to target in vivo in a model of disseminated human lymphoma and in vitro by flow cytometry and cell-based immunoreactivity assays versus appropriate controls. Conclusion: The key achievement in these studies was the selective targeting of tumor in vitro and in vivo by the use of specific antibodies appended to a soluble, nanoscale CNT construct. The ability to specifically target tumor with prototype-radiolabeled or fluorescent-labeled, antibody-appended CNT constructs was encouraging and suggested further investigation of CNT as a novel delivery platform.
This paper references
10.1126/SCIENCE.1114397
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
C. Ruegg (1990)
Synthesis and in vitro testing of J591 antibodydendrimer conjugates for targeted prostate cancer therapy
AK Patri (2004)
10.1016/0969-8051(94)00126-5
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies.
T. Nikula (1995)
10.1007/3-540-39947-X_1
Introduction to Carbon Materials Research
M. Dresselhaus (2001)
10.1073/pnas.072699999
Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials
J. D. Hartgerink (2002)
10.1021/BC015561+
Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.
R. J. Kok (2002)
10.1021/BM0506142
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
I. Majoros (2006)
10.1038/sj.leu.2402320
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies
D. Ma (2002)
10.1166/JNN.2004.146
Biodistribution of carbon single-wall carbon nanotubes in mice.
H. Wang (2004)
Impact of the high tyrosine fraction in complementary determining regions: measured and predicted effects of radioiodination on IgG radioimmunotherapy
TK Nikula (1995)
10.1016/S0008-6223(01)00234-2
Complete elimination of metal catalysts from single wall carbon nanotubes
D. Chattopadhyay (2002)
10.1039/B209843A
Amino acid functionalisation of water soluble carbon nanotubes.
V. Georgakilas (2002)
10.1016/0003-9861(59)90090-6
Tissue sulfhydryl groups.
G. Ellman (1959)
Vaccine delivery by carbon nanotubes.
M. in het Panhuis (2003)
10.1073/PNAS.0509009103
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.
R. Singh (2006)
10.1021/JA044293Y
Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
A. Bianco (2005)
10.1021/JA0486059
Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells.
Nadine Wong Shi Kam (2004)
10.1039/B516309A
Double functionalization of carbon nanotubes for multimodal drug delivery.
Giorgia Pastorin (2006)
Biodistribution of carbon single-wall nanotubes in mice
H Wang (2004)
10.1021/JA0466311
Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells.
P. Cherukuri (2004)
10.1182/BLOOD-2005-05-1860
CCR2 is required for CD8-induced graft-versus-host disease.
T. Terwey (2005)
10.1038/74455
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
Jean-Baptiste Latouche (2000)
10.1073/PNAS.87.15.5702
Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.
B. Müller (1990)
10.1016/0161-5890(95)00052-G
Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.
T. Nikula (1995)
10.1073/PNAS.0502680102
Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction.
N. W. Kam (2005)
10.1080/713853956
Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells
A. Shvedova (2003)
10.1158/1078-0432.CCR-04-0789
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
K. Hamblett (2004)
10.1016/0003-2697(81)90704-1
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.
V. Sarin (1981)
Preparation and Functional Evaluation of RGD-Modified Proteins as r v â 3 Integrin Directed Therapeutics
R. J. Kok
10.1039/B311254C
Translocation of bioactive peptides across cell membranes by carbon nanotubes.
D. Pantarotto (2004)
10.1016/S0969-8043(02)00167-7
Design and synthesis of 225Ac radioimmunopharmaceuticals.
M. McDevitt (2002)
10.1073/PNAS.92.15.6733
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
I. Rivière (1995)
10.1021/NL061160X
Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells.
H. Dumortier (2006)
nanotubes
V Georgakilas (2002)
10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.
M. Mammen (1998)
10.1002/IJC.2910450318
Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid mice
M. A. Ghetie (1990)
10.1073/PNAS.81.9.2843
Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection.
R. Sharkey (1984)
10.1021/BC050348P
HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
R. Shukla (2006)
10.1021/NL060765Q
Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging.
V. S. Talanov (2006)
Design and synthesis of 225 Ac radioimmunopharmaceuticals
Mr Mcdevitt (2002)
10.1021/BC0499127
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.
A. Patri (2004)
New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
J. M. Esteban (1987)
10.1016/S0969-8051(99)00054-2
Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand-protein conjugates.
E. Dadachova (1999)
10.1016/J.TOXLET.2005.08.011
Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro.
C. Sayes (2006)
10.1126/SCIENCE.1064126
Tumor Therapy with Targeted Atomic Nanogenerators
M. McDevitt (2001)



This paper is referenced by
10.4314/IJMU.V6I1.63972
Nanoparticles in Nuclear Imaging
Vicky V. Mody (2011)
10.1504/IJNT.2011.044433
Functionalised carbon nanotubes: high biocompatibility with lack of toxicity
M. A. Herrero (2011)
10.1007/s00432-015-2067-2
Radionuclide therapy using 131I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression
Wei Li (2015)
Synthesis, characterization and cytotoxicity evaluation of carboxylated carbon nanotubes functionalized with silibinin, betulinic acid and levodopa for drug delivery
Julia Meihua Tan (2015)
Carbon nanotubes in nanomedicine
Ramy ElSayed (2016)
10.1016/j.bios.2012.12.010
Improving immunosensor performance through oriented immobilization of antibodies on carbon nanotube composite surfaces.
S. Puertas (2013)
10.1186/2191-219X-2-39
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique
AndréLuís Branco de Barros (2012)
10.1002/9783527692866.CH3
Biodistribution and Pharmacokinetics of Carbon Nanomaterials In Vivo
Sheng-Tao Yang (2016)
10.1016/J.MSEB.2017.06.002
Functionalized carbon nanotubes in bio-world: Applications, limitations and future directions
Sireesha Merum (2017)
10.3390/bios7010009
Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment
A. Sanginario (2017)
10.1021/nn900904h
In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes.
H. K. Moon (2009)
10.1007/s11523-018-0550-9
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
M. Makvandi (2018)
10.1021/acs.chemrev.5b00367
A Systematic Framework and Nanoperiodic Concept for Unifying Nanoscience: Hard/Soft Nanoelements, Superatoms, Meta-Atoms, New Emerging Properties, Periodic Property Patterns, and Predictive Mendeleev-like Nanoperiodic Tables.
D. Tomalia (2016)
10.1039/c6cs00517a
Carbon nanotubes: a novel material for multifaceted applications in human healthcare.
S. Kumar (2017)
10.1016/J.CLAY.2015.04.018
Layered double hydroxide nanoparticles for biomedical applications: Current status and recent prospects
Yaswanth Kuthati (2015)
10.1007/978-3-642-31960-0_5
Applications of Carbon Nanotubes in Oncology
V. Yurgel (2013)
10.1002/cmmi.1542
Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T.
J. Rosenberg (2014)
10.1155/2014/439873
Characterization and in vitro sustained release of silibinin from pH responsive carbon nanotube-based drug delivery system
J. Tan (2014)
10.3390/polym9010013
Applications of Functionalized Carbon Nanotubes for the Therapy and Diagnosis of Cancer
Yongsung Hwang (2017)
10.1021/acsnano.5b03708
Carbon Nanotube Degradation in Macrophages: Live Nanoscale Monitoring and Understanding of Biological Pathway.
D. Elgrabli (2015)
FOTOAKTIVNE NANO^ESTICE U ONKOLOGIJI
Zoran S. Markovi (2010)
10.1016/J.TRAC.2013.03.005
Analytical strategies for real-time, non-invasive tracking of carbon nanomaterials in vivo
Aijuan Liu (2013)
10.1002/9783527800681.CH18
An overview of nanoparticle biocompatibility for their use in Nanomedicine
Matthew S. P. Boyles (2017)
10.1016/j.addr.2013.08.005
Carbon nanotubes for delivery of small molecule drugs.
B. Wong (2013)
10.2217/nnm.11.64
Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.
A. Tan (2011)
10.7150/thno.3618
Pharmacokinetics, Metabolism and Toxicity of Carbon Nanotubes for Biomedical Purposes
Sheng-Tao Yang (2012)
10.1002/jat.1742
Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF‐conjugated, single‐walled carbon nanotubes
Alokita Karmakar (2012)
Radioimmunotherapy-based treatment of cancer
S. Farrokhi (2012)
10.13074/jent.2015.12.15417558
Toxicology of Carbon Nanotubes - A Review
P. Khalid (2016)
10.1186/1556-276X-6-555
The application of carbon nanotubes in target drug delivery systems for cancer therapies
Wuxu Zhang (2011)
10.1016/j.nano.2009.02.006
Influence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes with human neuroblastoma cells.
O. Vittorio (2009)
10.1016/j.biomaterials.2011.10.060
Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery.
A. Guven (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar